# Lam Research (LRCX) Q4 China revenue mix <30%?

<table class="pythia-summary">
<tr><th>Predicted at</th><td>2026-07-22 09:44 UTC</td></tr>
<tr><th>Prediction</th><td><strong>55.0%</strong></td></tr>
<tr><th>Market (at prediction)</th><td>45.0%</td></tr>
<tr><th>Market (live)</th><td><span class="pythia-live-price" data-token-id="858877894375863799502845681416705907858900211064996516458037220693232175896">—</span></td></tr>
</table>

## Analysis

In the most recent Q3 2026 earnings report, Lam Research disclosed that China accounted for 34% of its total revenue mix. Management has provided forward-looking guidance indicating an expectation for this geographic concentration to normalize toward lower levels in subsequent periods. While recent public filings show the company remains above the 30% mark, the anticipated shift aligns with broader industry trends regarding regional demand. This forecast incorporates both the historical data from the latest earnings transcript and proprietary signals regarding the pace of this revenue transition. The outlook reflects the tension between current elevated exposure and the stated trajectory toward a smaller share of total sales.

## Key Evidence

Verified via transcript: Q3 China mix 34% (~$1.99B of $5.84B); Q4 guided $6.6B ±$0.4B on non-China AI demand; management explicitly said China revenue "will decline from these levels" in the June quarter. Flat China dollars at midpoint = 30.1% mix, so any actual dollar decline (supported by the April 28 Hua Hong shipment halt and the 50% affiliate rule ~$600M FY impact) pushes the reported figure to ≤29% → YES.

## Risks

Secondary risk: a total revenue miss toward $6.2B raising the required China dollar decline to ~8%.

---

[View on Polymarket](https://polymarket.com/event/2978039)